Percheron Therapeutics (AU:PER) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics Limited has announced the quotation of 135,231,746 ordinary fully paid securities on the Australian Securities Exchange, effective October 25, 2024. This move is part of a previously notified transaction and may interest investors keen on burgeoning opportunities within the biotech sector.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.